Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. Its Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer. The company's Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, post-concussion rehabilitation, pediatric and cancer rehabilitation, and athletic training services. Its Concentra segment operates and provides occupational health centers and contract services at employer worksites that deliver occupational medicine, physical therapy, and consumer health services, as well as provides veterans' healthcare services. As of December 31, 2020, the company operated 99 critical illness recovery hospitals in 28 states; 30 rehabilitation hospitals in 12 states; 1,788 outpatient rehabilitation clinics in 37 states and the District of Columbia; and 517 occupational health centers, and 134 onsite clinics at employer worksites states. Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania.
IPO Year: 2009
Exchange: NYSE
Website: selectmedical.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/16/2025 | $25.00 | Outperform | Mizuho |
| 2/24/2025 | $23.00 | Hold → Buy | The Benchmark Company |
| 11/25/2024 | Buy → Hold | The Benchmark Company | |
| 8/20/2024 | $42.00 | Buy | BofA Securities |
| 3/7/2022 | $47.00 → $42.00 | Outperform | RBC Capital |
| 1/18/2022 | $40.00 → $35.00 | Buy | B of A Securities |
| 1/18/2022 | $50.00 → $47.00 | Outperform | RBC Capital |
| 8/10/2021 | $37.00 → $39.00 | Neutral | Credit Suisse |
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
8-K - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)
8-K - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)
10-Q - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)
8-K - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)
10-Q - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)
8-K - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)
144 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
DEFA14A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)
DEF 14A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)
PRE 14A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)
Fastest customizable press release news feed in the world
MECHANICSBURG, Pa., July 31, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) today announced results for its second quarter ended June 30, 2025, and the declaration of a cash dividend. For the second quarter ended June 30, 2025, revenue increased 4.5% to $1,339.6 million, compared to $1,281.7 million for the same quarter, prior year. Income from continuing operations before other income and expense increased 17.2% to $86.5 million for the second quarter ended June 30, 2025, compared to $73.9 million for the same quarter, prior year. Income from continuing operations, net of tax, increased 53.8% to $57.9 million for the second quar
MECHANICSBURG, Pa., June 27, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its second quarter ended June 30, 2025 on Thursday, July 31, 2025 after the market closes. Select Medical will host a conference call regarding its second quarter results, as well as its business outlook, on Friday, August 1, 2025, at 9:00am ET. The conference call will be a live webcast and can be accessed at via this Earnings Call Webcast Link or via link at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call through the same link. For listene
MECHANICSBURG, Pa., June 27, 2025 /PRNewswire/ -- Select Medical Corporation today announced it signed a membership interest purchase agreement with Ballad Health to jointly operate Select Specialty Hospital – Tri-Cities, a critical illness recovery hospital in Kingsport, Tenn. The facility, licensed as long-term acute care, will be a hospital-in-hospital located in Ballad Health's Indian Path Community Hospital. Select Medical will serve as the majority owner and managing partner of the 46-bed joint venture hospital with Ballad Health. The hospital, which is currently owned and operated by Select Medical, will relocate from Ballad Health's Bristol Regional Medical Center to Indian Path Co
MECHANICSBURG, Pa., May 1, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) today announced results for its first quarter ended March 31, 2025, and the declaration of a cash dividend. For the first quarter ended March 31, 2025, revenue increased 2.4% to $1,353.2 million, compared to $1,321.2 million for the same quarter, prior year. Income from continuing operations before other income and expense was $112.7 million for the first quarter ended March 31, 2025, compared to $118.5 million for the same quarter, prior year. Income from continuing operations, net of tax, increased 21.5% to $74.7 million for the first quarter ended March
MECHANICSBURG, Pa., April 8, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM), will release the financial results for its first quarter ended March 31, 2025 on Thursday, May 1, 2025 after the market closes. Select Medical will host a conference call regarding its first quarter results, as well as its business outlook, on Friday, May 2, 2025, at 9:00am ET. The conference call will be a live webcast and can be accessed at via this Earnings Call Webcast Link or via link at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call through the same link. For listeners wish
MECHANICSBURG, Pa., Feb. 20, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) today announced results for its fourth quarter and year ended December 31, 2024, its 2025 business outlook, and the declaration of a cash dividend. On November 25, 2024, we completed a tax-free distribution of 104,093,503 shares of common stock of Concentra Group Holdings Parent, Inc. ("Concentra") to our stockholders. Holders of our common stock received 0.806971 shares of Concentra common stock for each outstanding share of our common stock owned as of November 18, 2024. Following the completion of the distribution, we no longer own any shares of Concen
MECHANICSBURG, Pa., Jan. 23, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM), will release the financial results for its fourth quarter and year ended December 31, 2024 on Thursday, February 20, 2025 after the market closes. Select Medical will host a conference call regarding its fourth quarter and full year results, as well as its business outlook, on Friday, February 21, 2025, at 9:00am ET. The conference call will be a live webcast and can be accessed at via this Earnings Call Webcast Link or via link at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call t
MECHANICSBURG, Pa., Dec. 3, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Holdings") (NYSE:SEM), today announced that Select Medical Corporation, a wholly-owned subsidiary of Holdings ("Select"), has completed a private offering (the "Offering") of $550.0 million in aggregate principal amount of its 6.250% senior notes due 2032 (the "notes"). The notes are senior unsecured obligations of Select and are guaranteed by certain of Select's existing and future domestic subsidiaries. Select used the net proceeds of the Offering, together with the proceeds from the new incremental term loan and cash on hand, to repay in full the term loans currently outstanding under Select's existing
MECHANICSBURG, Pa., Nov. 25, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) today announced that we have completed our previously announced distribution (the "Distribution") of 104,093,503 shares of common stock of Concentra Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) owned by Select Medical Corporation ("SMC"), a wholly owned subsidiary of Select Medical, representing approximately 81.7% of the outstanding shares of Concentra's common stock. After the completion of the Distribution, Select Medical no longer owns any shares of Concentra's common stock. The Distribution was made today to Select Medical's stockholders as o
Concentra Group Holdings Parent, Inc. ("Concentra," "we," "us," or "our") (NYSE:CON) today announced that Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM) has completed its previously announced distribution (the "Distribution") of 104,093,503 shares of Concentra's common stock owned by Select Medical Corporation ("SMC"), a wholly owned subsidiary of Select Medical, representing approximately 81.7% of the outstanding shares of Concentra's common stock. After the completion of the Distribution, Select Medical no longer owns any shares of Concentra's common stock. The Distribution was made today to Select Medical's stockholders as of the close of business on November 18, 202
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Mizuho initiated coverage of Select Medical with a rating of Outperform and set a new price target of $25.00
The Benchmark Company upgraded Select Medical from Hold to Buy and set a new price target of $23.00
The Benchmark Company downgraded Select Medical from Buy to Hold
BofA Securities resumed coverage of Select Medical with a rating of Buy and set a new price target of $42.00
RBC Capital reiterated coverage of Select Medical Holdings with a rating of Outperform and set a new price target of $42.00 from $47.00 previously
B of A Securities reiterated coverage of Select Medical Holdings with a rating of Buy and set a new price target of $35.00 from $40.00 previously
RBC Capital reiterated coverage of Select Medical Holdings with a rating of Outperform and set a new price target of $47.00 from $50.00 previously
Credit Suisse reiterated coverage of Select Medical Holdings with a rating of Neutral and set a new price target of $39.00 from $37.00 previously
The Benchmark Company reiterated coverage of Select Medical with a rating of Buy and set a new price target of $44.00 from $40.00 previously
Deutsche Bank reiterated coverage of Select Medical Holdings with a rating of Buy and set a new price target of $46.00 from $42.00 previously
Live finance-specific insights
MECHANICSBURG, Pa., July 31, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) today announced results for its second quarter ended June 30, 2025, and the declaration of a cash dividend. For the second quarter ended June 30, 2025, revenue increased 4.5% to $1,339.6 million, compared to $1,281.7 million for the same quarter, prior year. Income from continuing operations before other income and expense increased 17.2% to $86.5 million for the second quarter ended June 30, 2025, compared to $73.9 million for the same quarter, prior year. Income from continuing operations, net of tax, increased 53.8% to $57.9 million for the second quar
MECHANICSBURG, Pa., June 27, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its second quarter ended June 30, 2025 on Thursday, July 31, 2025 after the market closes. Select Medical will host a conference call regarding its second quarter results, as well as its business outlook, on Friday, August 1, 2025, at 9:00am ET. The conference call will be a live webcast and can be accessed at via this Earnings Call Webcast Link or via link at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call through the same link. For listene
MECHANICSBURG, Pa., May 1, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) today announced results for its first quarter ended March 31, 2025, and the declaration of a cash dividend. For the first quarter ended March 31, 2025, revenue increased 2.4% to $1,353.2 million, compared to $1,321.2 million for the same quarter, prior year. Income from continuing operations before other income and expense was $112.7 million for the first quarter ended March 31, 2025, compared to $118.5 million for the same quarter, prior year. Income from continuing operations, net of tax, increased 21.5% to $74.7 million for the first quarter ended March
MECHANICSBURG, Pa., April 8, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM), will release the financial results for its first quarter ended March 31, 2025 on Thursday, May 1, 2025 after the market closes. Select Medical will host a conference call regarding its first quarter results, as well as its business outlook, on Friday, May 2, 2025, at 9:00am ET. The conference call will be a live webcast and can be accessed at via this Earnings Call Webcast Link or via link at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call through the same link. For listeners wish
MECHANICSBURG, Pa., Jan. 23, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM), will release the financial results for its fourth quarter and year ended December 31, 2024 on Thursday, February 20, 2025 after the market closes. Select Medical will host a conference call regarding its fourth quarter and full year results, as well as its business outlook, on Friday, February 21, 2025, at 9:00am ET. The conference call will be a live webcast and can be accessed at via this Earnings Call Webcast Link or via link at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call t
MECHANICSBURG, Pa., Oct. 1, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its third quarter ended September 30, 2024 on Thursday, October 31, 2024 after the market closes. Select Medical will host a conference call regarding its third quarter results, as well as its business outlook, on Friday, November 1, 2024, at 9:00am ET. The conference call will be a live webcast and can be accessed at via this Earnings Call Webcast Link or via link at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call through the same link. For
MECHANICSBURG, Pa., July 12, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) today announced an estimate of certain financial results of its wholly-owned subsidiary, Concentra Group Holdings Parent, Inc. ("Concentra"), for the second quarter ended June 30, 2024 in advance of the announcement of Select Medical's actual results, which is expected to occur after market close on Thursday, August 1, 2024. Select Medical expects Concentra's net operating revenue for its second quarter of 2024 to be approximately $477.9 million. Select Medical expects Concentra's income from operations for the second quarter of 2024 to be approximately $
MECHANICSBURG, Pa., June 28, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM), will release the financial results for its second quarter ended June 30, 2024 on Thursday, August 1, 2024 after the market closes. Select Medical will host a conference call regarding its second quarter results, as well as its business outlook, on Friday, August 2, 2024, at 9:00am ET. The conference call will be a live webcast and can be accessed at via this Earnings Call Webcast Link or via link at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call through the same link. For listene
MECHANICSBURG, Pa., June 26, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select") (NYSE:SEM) and Concentra Group Holdings Parent, Inc. ("Concentra"), today announced that Concentra Escrow Issuer Corporation ("Issuer"), a wholly-owned subsidiary of Concentra Health Services, Inc. ("CHSI"), has priced its offering of $650 million aggregate principal amount of 6.875% senior notes due 2032. The notes are being offered in connection with Select's previously announced plan to pursue a separation of Concentra, its wholly-owned occupational health services business (the "Separation"). As a step in the process of effectuating the Separation and subject to satisfaction of certain condit
MECHANICSBURG, Pa., June 25, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select") (NYSE:SEM) and Concentra Group Holdings Parent, Inc. ("Concentra") today announced that Concentra Escrow Issuer Corporation ("Issuer"), a wholly-owned subsidiary of Concentra Health Services, Inc. ("CHSI"), commenced an offering of $750 million in aggregate principal amount of senior notes due 2032. The notes are being offered in connection with Select's previously announced plan to pursue a separation of Concentra, its wholly-owned occupational health services business (the "Separation"). As a step in the process of effectuating the Separation and subject to satisfaction of certain conditions, i
Live Leadership Updates
NEW YORK, Nov. 19, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Flex Ltd (NASD: FLEX) will replace Azenta Inc. (NASD: AZTA) in the S&P MidCap 400, and Azenta will replace Envestnet Inc. (NYSE:ENV) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, November 25. Bain Capital is acquiring Envestnet in a deal expected to be completed soon, pending final closing conditions. Azenta's market capitalization is no longer representative of the mid-cap market space.Concentra Group Holdings Inc. (NYSE:CON) will replace Myers Industries Inc. (NYSE:MYE) in the S&P SmallCap 600 effective prior to the openin
MECHANICSBURG, Pa., Nov. 2, 2021 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM) today announced the appointment of Parvinderjit Singh Khanuja, M.D. to its Board of Directors (the "Board"), effective on November 1, 2021. Dr. Khanuja's Board term will expire at Select Medical's 2023 Annual Meeting of Stockholders, at which time he will stand for election along with the other director nominees standing for election at that meeting. "We are very pleased to welcome Dr. Khanuja to the Select Medical Board of Directors," said Robert A. Ortenzio, Executive Chairman and Co-Founder of Select Medical. "Dr. Khanuja brings to Select Medical over three decades of experi
MECHANICSBURG, Pa., April 16, 2021 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM) today announced the appointment of Katherine R. Davisson to its Board of Directors (the "Board"), effective immediately. Ms. Davisson's Board term will expire at Select Medical's 2022 Annual Meeting of Stockholders, at which time she will stand for election along with the other director nominees standing for election at that meeting. "We are very pleased to welcome Katherine Davisson to the Select Medical Board of Directors," said Robert A. Ortenzio, Executive Chairman and Co-Founder of Select Medical. "Ms. Davisson brings to Select Medical over two decades of financial servi
This live feed shows all institutional transactions in real time.
SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
SC 13G - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
SC 13G - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)